After getting a metastatic breast cancer diagnosis, you may experience anxiety and depression. Here are some ways to manage ...

The TGA has issued a requirement for new warnings to be provided with the drug montelukast, commonly used to treat asthma and ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...

The first randomized control trial of the school-based intervention called Supporting Transition Resilience of Newcomer Groups (STRONG) shows significant reductions in depression, anxiety and behavior ...

Graham, also from West Yorkshire, said he had been paying less than £100 a month for his ADHD medication since going private ...

As some of you will have children or grand-children facing a new school year - anxiety for kids can be a big deal. Below are some of my thoughts on that.I am a diagnosed social-phobe. I find ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).

Many with ADHD report that medication — typically a stimulant but treatment can also include non-stimulants and ...

Encephalitis survivors experience hidden mental health struggles and there is an urgent need for improved support within the ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...